Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.
    Difference
    0.1%
    Check dated 2026-02-20T20:25:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.4.1 to v3.4.2, a minor update with no changes to the study data or display. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:53:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 as the site version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:49:27.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Minor UI and wording updates were made, including glossary show/hide options, capitalization tweaks in QC criteria labels, and revision/version strings (v3.4.0 added, v3.3.4 removed). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:51:43.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears in the page revision history, replacing v3.3.3; no study content or essential information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:43:04.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page reorganizes location information by adding a general 'Locations' section and listing states (California, Colorado, Massachusetts, Michigan). The 'HHS Vulnerability Disclosure' link is removed and the revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T20:35:52.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.